Dr. Chris Lamb of Newcastle University was a keynote speaker during the ECCO European Crohn’ and Colitis Organisation Congress held on February 21st -24th in Stockholm. His plenary talk with Cate Titterton focused on the similarities and differences between patient and clinician endpoints in therapy.
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853981. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and PARKINSON’S DISEASE SOCIETY OF THE UNITED KINGDOM LBG.
